The Food and Drug Administration names a liquid form of albuterol on its list of ongoing drug shortages, though Dr. Ryan Murphy says UW Medicine's pharmacies have ample supply at this time.

"Patients haven't felt this quite yet that are requiring nebulized albuterol. I've told them to kind of expect it over the coming months, but so far, they haven't had issues getting the medication," said Murphy, an acting instructor of pulmonary critical care and sleep medicine at the University of Washington School of Medicine.

In a blog post, Murphy describes how liquid albuterol differs from the form of albuterol commonly used in canister inhalers — which is not facing a shortage.

Download broadcast-ready soundbites about liquid albuterol and advice for people who might become affected by the shortage.